Nantahala Capital Management’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $748K | Sell |
|
|||||
|
2023
Q2 | $1.05M | Sell |
|
|||||
|
2023
Q1 | $913K | Sell |
|
|||||
|
2022
Q4 | $3.08M | Buy |
|
|||||
|
2022
Q3 | $968K | Sell |
|
|||||
|
2022
Q2 | $934K | Sell |
|
|||||
|
2022
Q1 | $2.26M | Sell |
|
|||||
|
2021
Q4 | $2.06M | Sell |
|
|||||
|
2021
Q3 | $2.34M | Sell |
|
|||||
|
2021
Q2 | $2.67M | Hold |
|
|||||
|
2021
Q1 | $2.91M | Sell |
|
|||||
|
2020
Q4 | $2.59M | Sell |
|
|||||
|
2020
Q3 | $2.85M | Hold |
|
|||||
|
2020
Q2 | $3.4M | Hold |
|
|||||
|
2020
Q1 | $1.97M | Hold |
|
|||||
|
2019
Q4 | $3.97M | Hold |
|
|||||
|
2019
Q3 | $3.16M | Hold |
|
|||||
|
2019
Q2 | $3.86M | Buy |
|
|||||
|
2019
Q1 | $21.5M | Sell |
|
|||||
|
2018
Q4 | $18.2M | Buy |
|
|||||
|
2018
Q3 | $21.3M | Buy |
|
|||||
|
2018
Q2 | $5.41M | Hold |
|
|||||
|
2018
Q1 | $4.82M | Buy |
|